More on ZBIO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $25.26 |
|
|||
| Open | $24.58 | ||||
| 52 Wk High | $50.95 | ||||
| 52 Wk Low | $18.06 | ||||
| Day High | $25.49 | ||||
| Day Low | $24.21 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 291,766 | ||||
- Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Zenas BioPharma, Inc. (NASDAQ: ZBIO)
- Form 4 Zenas BioPharma, Inc. For: Feb 11 Filed by: Lu Hongbo
- Form 4 Zenas BioPharma, Inc. For: Feb 12 Filed by: Allen Patricia L
- Form 8-K Zenas BioPharma, Inc. For: Feb 10
- Zenas BioPharma drug meets primary endpoint in multiple sclerosis trial
- Zenas BioPharma Announces Late-Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026
- Form SCHEDULE 13G/A Zenas BioPharma, Inc. Filed by: FMR LLC
- Zenas BioPharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
- Form 4 Zenas BioPharma, Inc. For: Feb 02 Filed by: MOULDER LEON O JR
Entities mentioned with ZBIO
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- FDA | View Related Stories »
- Show More...
